An agent CRM platform used to promote global unified interaction

Pleasanton, California, November 4, 2026 / PRNewswire / -- Veeva Systems ( NYSE : VEEV ) Today, we announce that UCB has committed to adopting Veeva Vault CRM, an agent interaction platform tailored for the life sciences industry. Vault CRM integrates specialized artificial intelligence for this industry to accelerate product launch and improve the customer experience.

UCB, the head of digital technology, Edwin Erckens said: "We are very pleased to strengthen our strategic partnership with Veeva by adopting Vault CRM. We both have a deep commitment to customer success, and Vault CRM will provide the technical foundation needed for UCB to optimize the execution of its business strategy."

Veeva European President Chris Moore stated: “Vault CRM is a customer interaction platform that will provide UCB with a stable, scalable, and future-oriented technical infrastructure, driving its business strategy forward. By collaborating side by side with UCB, we will support them in accomplishing this important mission.”

Vault CRM is a part of Vault CRM Suite, which is a technical platform for agent-based commercial activities. The agent call reports in Vault CRM can generate substantiated business data, thereby revealing previously hidden barriers to treatment.

About Veeva Systems

Veeva provides cloud platforms for the life sciences industry, covering applications, agents, data, and consulting services. Veeva is committed to innovation, excellence in products, and customer success, with over 1,500 clients, including the world's largest biopharmaceutical companies and emerging biotech startups. As a nonprofit organization, Veeva strives to balance the interests of all stakeholders as much as possible, including customers, employees, shareholders, and the industries it serves. For more information, please visit veeva.com.

Veeva Forward-looking Statement

This press release contains forward-looking statements regarding Veeva products and services, as well as the expected results or benefits from using our products and services. These statements are based on our current expectations. Actual results may differ significantly from those described in this press release, and we have no obligation to update these statements. There are numerous risks that may have an adverse effect on our performance, including those mentioned in our 10-Q report for the fiscal quarter ending July 31, 2026, which can be found in this document (a summary of risks that may affect our business is on pages 33 and 34), as well as in subsequent documents submitted to the U.S. Securities and Exchange Commission (SEC). These documents can be viewed at sec.gov.